The project will also investigate the role of a physiologically relevant modulator of mtG signalling, such as the G Protein-Coupled Cannabinoid Receptor (CB1), which is partially localized on brain ...

Inversago Pharma, based in Montreal, Canada, is working on safer generations of peripherally-acting cannabinoid receptor-1 (CB1) inverse agonists, based on research carried out by George Kunos ...